tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BNXTF Stock Latest News

BioNxt Boosts Investor Relations Efforts With New Mandates and 5.15 Million Option Grants
Company AnnouncementsBioNxt Boosts Investor Relations Efforts With New Mandates and 5.15 Million Option Grants
24d ago
BioNxt Wipes Out $2.7 Million Debt Through Share Issuance
PremiumCompany Announcements
BioNxt Wipes Out $2.7 Million Debt Through Share Issuance
25d ago
BioNxt Moves to Retire $2.7 Million in Debenture Debt via Share Issuance
PremiumCompany Announcements
BioNxt Moves to Retire $2.7 Million in Debenture Debt via Share Issuance
2M ago
BioNxt’s Sublingual Cladribine Film Delivers 40% Higher Exposure in Preclinical MS Study
PremiumCompany Announcements
BioNxt’s Sublingual Cladribine Film Delivers 40% Higher Exposure in Preclinical MS Study
2M ago
BioNxt’s Cladribine Film Shows Superior Bioavailability in Preclinical MS Study
PremiumCompany Announcements
BioNxt’s Cladribine Film Shows Superior Bioavailability in Preclinical MS Study
2M ago
BioNxt Advances Thin-Film Drug Platform With First Patent for Sublingual Cladribine
PremiumCompany AnnouncementsBioNxt Advances Thin-Film Drug Platform With First Patent for Sublingual Cladribine
2M ago
BioNxt Signs Agreement for Sublingual Chemotherapy and Immunosuppressant Innovation
Premium
Company Announcements
BioNxt Signs Agreement for Sublingual Chemotherapy and Immunosuppressant Innovation
3M ago
BioNxt Secures Eurasian Patent for Sublingual Cladribine Platform
Premium
Company Announcements
BioNxt Secures Eurasian Patent for Sublingual Cladribine Platform
3M ago
BioNxt Unveils Innovative Oral Film to Transform MS Treatment
PremiumCompany Announcements
BioNxt Unveils Innovative Oral Film to Transform MS Treatment
3M ago
BioNxt Secures Eurasian Patent Readiness for Sublingual Drug Delivery
PremiumCompany Announcements
BioNxt Secures Eurasian Patent Readiness for Sublingual Drug Delivery
5M ago
BioNxt Secures European Patent for Innovative MS Treatment
PremiumCompany Announcements
BioNxt Secures European Patent for Innovative MS Treatment
5M ago
BioNxt Solutions Completes Debt Settlement to Strengthen Financial Position
PremiumCompany Announcements
BioNxt Solutions Completes Debt Settlement to Strengthen Financial Position
5M ago
BioNxt Solutions Advances Cladribine Formulation with New Study
PremiumCompany AnnouncementsBioNxt Solutions Advances Cladribine Formulation with New Study
5M ago
BioNxt Reports “Readiness to Grant” Patent Notification from the Eurasian Patent Organization
Premium
TipRanks Newswire
BioNxt Reports “Readiness to Grant” Patent Notification from the Eurasian Patent Organization
5M ago
BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug
Premium
TipRanks Newswire
BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug
5M ago
BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study
PremiumTipRanks Newswire
BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study
5M ago
BioNxt Advances Cladribine Sublingual Film for MS Treatment
PremiumCompany Announcements
BioNxt Advances Cladribine Sublingual Film for MS Treatment
5M ago
BioNxt Solutions Adapts AGM Voting Amid Postal Strike and Launches Marketing Campaign
PremiumCompany Announcements
BioNxt Solutions Adapts AGM Voting Amid Postal Strike and Launches Marketing Campaign
5M ago
BioNxt Advances Semaglutide Oral Film with Successful Trials
PremiumCompany Announcements
BioNxt Advances Semaglutide Oral Film with Successful Trials
5M ago
BioNxt Advances Targeted Chemotherapy Delivery Platform
PremiumCompany AnnouncementsBioNxt Advances Targeted Chemotherapy Delivery Platform
5M ago
BioNxt Solutions Strengthens Market Position with Strategic Advisor and Investor Relations Team
Premium
Company Announcements
BioNxt Solutions Strengthens Market Position with Strategic Advisor and Investor Relations Team
5M ago
BioNxt Solutions Completes Debt Settlement to Strengthen Financial Position
Premium
Company Announcements
BioNxt Solutions Completes Debt Settlement to Strengthen Financial Position
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >